EveTM CCHD Newborn
Screening Application
Eve combines Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with step-by-step instructions to assist clinicians in screening for Critical Congenital Heart Disease (CCHD)

Eve with CCHD


Eve simplifies the CCHD screening process, per an established protocol1, by providing visual instructions, animations, an automatic synchronization algorithm, and a detailed, easy-to-interpret display of screening results

Eve scan Eve criteria Eve settings Eve EMR

Animations provide visual guidance to assist clinicians through the screening process

An automatic synchronization algorithm, with an easy-to-interpret results screen, may reduce calculation errors

Settings allow clinicians to incorporate perfusion index (Pi) measurement, which may increase sensitivity to detection of CCHD2

EMR integration via Patient SafetyNet* or Iris Gateway facilitates workflow and may help reduce reporting errors


Step-By-Step Instruction Improves Consistency and Workflow Efficiency

STEP 1: Sensor Placement on Right Hand

STEP 2: Sensor Placement on Either Foot

STEP 3: Two Possible Screening Results

Eve step 3


CCHD Screening with Masimo SET® Pulse Oximetry

  • > In a study of 39,821 infants, CCHD screening sensitivity increased from 63% with physical exam alone to 83% with physical exam and Masimo SET® pulse oximetry.2
  • > In a study of 122,738 infants, CCHD screening sensitivity increased from 77% to 93% with the combined use of Masimo SET® and clinical assessment.3
CCHD screening


  • * The use of the trademark PATIENT SAFETYNET is under license from University HealthSystem Consortium.
  • 1 Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow WR, Kelm K, Pearson GD, Glidewell J, Grosse SD, Howell, RR. Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics. 2011 Oct; 128(5):1259-67.
  • 2 de-Wahl Granelli A et al. BMJ. 2009;338:a3037.
  • 3 Zhao et al. Lancet. 2014 Aug 30;384(9945):747-54.


Product Information

Eve has obtained CE Marking. Not available in the U.S. or Canada. Rad-97 is not licensed for sale in Canada.

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.